These data indicate clinically eloquent brain regions, usually deeply involved in the pathological substrate of MS, as those that have a minor degree of subtle myelin/axonal pathology in RIS subjects, providing a compelling reason for the lack of clinical manifestations existing in these subjects.
Risedronate (Ris) in powder form was provided by Procter and Gamble Pharmaceuticals Inc. (Cincinnati, OH, USA).
Double-ratio drqPCR as argued in the introduction, the double-ratio approach (Eq. I.4) can provide Ris-estimates if the control sample contains A and B in equal concentrations.
In a study of secondary OS including 17 RIS, Bielack et al (1999) concluded that, provided that local control is achieved, a patient with a secondary OS treated with modern combined modality therapy has a similar prognosis as patients with sporadic OS.
The rice seeds were kindly provided by the Rice Research Unit (CREA-RIS, Vercelli, Italy).
RIS helped in the interpretation of the data, provided critical review of the manuscript, and gave the final approval.
Similar survival rates in RIS and SPS patients have been reported by several investigators in adjusted analysis of limited cohorts, provided that the patient was treated according to modern treatment (Bielack et al, 1999; Leclercq et al, 2004; Shaheen et al, 2006).
While many participants considered the lack of consensus among specialists a major obstacle to the introduction of SR, they believed that ready-made reports provided by the PACS/RIS manufacturer would be used widely anyhow (quote 17; Table 2).
In this paper, a general description of typical integrated RIS PACS architecture with image processing capabilities will be provided, and the main available image processing tools will be illustrated.
Finally, we attempted an estimation here of the RIS subjects who were closer to RRMS on the basis of their quantitative MR metrics, providing a characterization of RIS subjects that fully matched with the occurrence of abnormal immunological pattern in these subjects.
We provide explicit tests of the RIS-predicted phenotypic and behavioral trait shifts (Table 1), by using the Licosa Island Wall lizard Podarcis sicula klemmeri as a model.
